Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Fc functional antibodies in humans with severe H7N9 and seasonal influenza
Hillary A. Vanderven, Lu Liu, Fernanda Ana-Sosa-Batiz, Thi H.O. Nguyen, Yanmin Wan, Bruce Wines, P. Mark Hogarth, Danielle Tilmanis, Arnold Reynaldi, Matthew S. Parsons, Aeron C. Hurt, Miles P. Davenport, Tom Kotsimbos, Allen C. Cheng, Katherine Kedzierska, Xiaoyan Zhang, Jianqing Xu, Stephen J. Kent
Hillary A. Vanderven, Lu Liu, Fernanda Ana-Sosa-Batiz, Thi H.O. Nguyen, Yanmin Wan, Bruce Wines, P. Mark Hogarth, Danielle Tilmanis, Arnold Reynaldi, Matthew S. Parsons, Aeron C. Hurt, Miles P. Davenport, Tom Kotsimbos, Allen C. Cheng, Katherine Kedzierska, Xiaoyan Zhang, Jianqing Xu, Stephen J. Kent
View: Text | PDF
Clinical Research and Public Health Immunology Infectious disease

Fc functional antibodies in humans with severe H7N9 and seasonal influenza

  • Text
  • PDF
Abstract

BACKGROUND. Both seasonal and novel avian influenza viruses can result in severe infections requiring hospitalization. Anti-influenza antibodies (Abs) with Fc-mediated effector functions, such as Ab-dependent cellular cytotoxicity (ADCC), are of growing interest in control of influenza but have not previously been studied during severe human infections. As such, the objective of this study was to examine Fc-mediated Ab functions in humans hospitalized with influenza infection. METHODS. Serum Ab response was studied in subjects hospitalized with either pandemic H7N9 avian influenza virus in China (n = 18) or circulating seasonal influenza viruses in Melbourne, Australia (n = 16). Recombinant soluble Fc receptor dimer ELISAs, natural killer (NK) cell activation assays, and Ab-dependent killing assays with influenza-infected target cells were used to assess the Fc functionality of anti-influenza hemagglutinin (HA) Abs during severe human influenza infection. RESULTS. We found that the peak generation of Fc functional HA Abs preceded that of neutralizing Abs for both severe H7N9 and seasonal influenza infections. Subjects who succumbed to complications of H7N9 infection demonstrated reduced HA-specific Fc receptor–binding Abs (in magnitude and breadth) immediately prior to death compared with those who survived. Subjects who recovered from H7N9 and severe seasonal influenza infections demonstrated increased Fc receptor–binding Abs not only against the homologous infecting strain but against HAs from different influenza A subtypes. CONCLUSION. Collectively, survivors of severe influenza infection rapidly generate a functional Ab response capable of mediating ADCC against divergent influenza viruses. Broadly binding HA Abs with Fc-mediated functions may be a useful component of protective immunity to severe influenza infection. FUNDING. The National Health and Medical Research Council ([NHMRC] grants 1023294, 1041832, and 1071916), the Australian Department of Health, and the joint University of Melbourne/Fudan University International Research and Research Training Fund provided funding for this study.

Authors

Hillary A. Vanderven, Lu Liu, Fernanda Ana-Sosa-Batiz, Thi H.O. Nguyen, Yanmin Wan, Bruce Wines, P. Mark Hogarth, Danielle Tilmanis, Arnold Reynaldi, Matthew S. Parsons, Aeron C. Hurt, Miles P. Davenport, Tom Kotsimbos, Allen C. Cheng, Katherine Kedzierska, Xiaoyan Zhang, Jianqing Xu, Stephen J. Kent

×

Figure 4

Breadth of Fc functional Abs generated during severe influenza infection.

Options: View larger image (or click on image) Download as PowerPoint
Breadth of Fc functional Abs generated during severe influenza infection...
Subjects infected with H7N9 influenza (A and C) and seasonal influenza A (B and D) were examined over time for breadth of dimeric rsFcγRIIIa (A and B) and rsFcγRIIa (C and D) against a range of HA proteins. Median rsFcγRIIIa (A) and rsFcγRIIa (C) dimer binding by serum Abs from 12 subjects who survived and 6 subjects who died from H7N9 infection is shown against HA proteins from the A/Shanghai/1/2013 (H7N9) virus (H7 Shanghai), the A/California/04/2009 (H1N1) virus (H1 Cali/09), the A/Japan/305/1957 (H2N2) virus (H2 Japan), the A/Perth/16/2009 (H3N2) virus (H3 Perth), the A/Swine/Ontario/01911-1/1999 (H4N6) virus (H4 Ontario), and the A/Vietnam/1194/2004 (H5N1) virus (H5 Vietnam). Median rsFcγRIIIa (B) and rsFcγRIIa (D) dimer binding by serum Abs from 12 subjects infected with seasonal influenza A viruses (of the H1N1 or H3N2 subtypes) and 10 influenza-negative subjects is shown for H1 Cali/09, H2 Japan, H4 Ontario, H5 Vietnam, and H7 Shanghai as well as for H3 proteins from the A/Switzerland/9715293/2013 (H3N2) and X-31 (H3N2) viruses. All influenza-infected and control subjects were background subtracted for dimeric rsFcγR binding by Abs against an irrelevant HIV-1 protein gp140. Data from individual subjects are shown in Supplemental Figures 4 and 5. All 6 HAs were analyzed concurrently with a Wilcoxon matched-pairs signed-rank test to compare hospital admission to hospital release/death in the H7N9-infected cohort (A and C). Similarly for the seasonal influenza-infected and uninfected subjects, all 7 HAs were analyzed concurrently with a Kruskal-Wallis test to compare hospital admission, hospital release/death, and 30 days after hospitalization (B and D). *P < 0.05, ***P < 0.001, ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts